04/28/2026
April 26 - May 2, 2026 is National Immunization Week in Canada!
This year, we're highlighting the recent report from Bridge Research Consortium (BRC) examining how people in Canada view mRNA technology and how they interact with information about mRNA technology online.
Canada is a global leader in the development of mRNA medicines. And yet, despite evidence of the safety of mRNA technology, public trust in these tools in Canada and the US is slow to develop, especially in online spaces.
“Advancements in next-generation RNA technologies have the potential to transform how we treat and prevent disease — but realizing that full potential in Canada hinges on understanding public concerns, proactively building trust, and strengthening our communication approaches,” says Rackeb Tesfaye, PhD, BRC Knowledge Mobilization Lead and Senior Scientist
Learn more about BRC's findings and their recommendations for addressing the many issues surrounding mRNA technology and its uptake: https://www.sfu.ca/fhs/news-events/news/2026/brc-report-highlights-perspectives-recommendations-on-mrna-technology.html
Researchers examined the perspectives of people in Canada towards mRNA technology. They seek to better understand perspectives and to make recommendations that could strengthen public trust and support for the adoption of immune-based innovations during health emergencies.